A systematic and detailed explanation of direct reprogramming technology that can induce differentiation into target cells efficiently and at low cost, with minimal risk of carcinogenesis!
◇ Following the forefront of research on direct programming technology, which is expected to be applied in regenerative medicine and cancer treatment! ◇ Systematically explaining direct programming technology that can induce differentiation into target cells efficiently and cost-effectively with minimal cancerization risk! ◇ Discussing the current status of direct programming technology, which is expected to be utilized in the future of regenerative medicine, including applications in drug discovery and personalized medicine! ◇ Providing a detailed explanation of direct programming technology that offers a new perspective on cell reprogramming research!
Inquire About This Product
basic information
"Direct Reprogramming: New Developments in Regenerative Medicine" ■Publication Date: August 2020 ■Price: 45,000 yen (excluding tax) ■Format: B5 size, 316 pages ■Supervised by: Atsushi Suzuki (Professor, Kyushu University Institute of Health and Defense Medicine) ■Published by: NTS Corporation ISBN978-4-86043-671-1 ■Table of Contents Introduction: Current Status and Future Prospects of Direct Reprogramming Research Part 1: Development of Direct Reprogramming Technologies Using Cell Fate Control Factors Part 2: Efforts Toward Medical Applications of Direct Reprogramming Part 3: Fundamental Technologies Supporting the Advancement of Direct Reprogramming
Price information
List price: 45,000 yen + tax
Price range
P2
Delivery Time
P2
Applications/Examples of results
Cell fate regulatory factors Microglia Artificial neuron regeneration Retinal nerve cells Neural crest cells Cardiac pacemaker cells Skeletal muscle stem cells Lung epithelial cells Hepatocytes Pancreatic β cells Type 1 diabetes Intestinal stem/progenitor cells Neurodegenerative disease treatment Corneal epithelial stem cell exhaustion treatment Muscular dystrophy drug screening Non-steroidal anti-inflammatory drug diclofenac Cancer cell control and tumor suppression Negative single-stranded RNA virus vector Recombinant artificial transcription factor protein Epigenome editing Transcriptome analysis Single-cell epigenome analysis technology Transcriptional regulatory networks Cell lineage trajectory estimation tools Data-driven direct reprogramming Organ regeneration through stem cell self-organization Mechanical stress
catalog（7）
Download All Catalogs
Company information
NTS selects reliable information from the overwhelming amount of information through seminars, publications, and literature information activities, and passes it on to the next generation. From abundance to certainty—that is the philosophy of NTS's activities.
